A B S T R A C T Acute clearance studies were performed in thyroparathyroidectomized animals to determine the actions and interactions of thyrocalcitonin (TCT), cyclic adenosine 3'5'-monophosphate (cAMP), 25-hydroxycholecalciferol (25HCC), and calcium ion on the reabsorption of phosphate, calcium, sodium, and potassium by the kidney. The infusion of 25HCC in a dosage of 60 U/h to moderately saline-expanded animals (2.5% body weight) induced a fall in the excretion of all of the ions under study after 90-120 min similar to that observed in previous experiments from this laboratory. Mean decrements in fractional excretion were: phosphate, 42.0% (P < 0.005); calcium, 25.0% (P < 0.005); sodium, 23.4% (P < 0.001); and potassium, 14.7% (P < 0.005). The superimposition of either porcine or salmon TCT (1-100 MRC U/h for 2 h) resulted in no further alterations in electrolyte excretion. However, the infusion of TCT during steady-state saline expansion, before the administration of 25HCC, obviated the renal transport effects of the vitamin D metabolite. Both in the latter studies, as well as those in whiicl similar doses of TCT were given to hydropenic animnals, the hormone itself failed to induce any consistent alteration in electrolyte excretion. Cyclic AMP (50 mg/h) caused an increase in the excretion of phosphate, sodium, and potassium and no change in calcium excretion. Like TCT, the nucleotide blocked the action of 25HCC on the kidney. Raising the mean level of serum ultrafilterable calcium to 3.02±0.25 mEq/liter from 1.62±0
INTRODUCTION
It is now well established that two of the factors which are important in controlling phosphate, calcium, and sodium transport in the nephron are parathyroid hormone (PTH)' and the status of the extracellular fluid volume (1) (2) (3) (4) (5) (6) (7) (8) (9) . The actions of PTH on renal transport can be largely, but not entirely reproduced by the administration of cyclic adenosine 3',5'monophosphate (cAMP) (10) (11) (12) (13) (14) . Recently, two additional agents which may play significant roles in the regulation of ionic transport in the kidney have been identified. These substances, thyrocalcitonin (TCT) and vitamin D, were originally considered to have effects directed only upon the skeleton and the gastrointestinal tract. However, it
The present studies were performed with the following aims: (a) to evaluate the efficacy of TCT and cAMP as well as alterations in extracellular fluid calcium concentration in initiating or modifying alterations in electrolyte transport in the kidney of the dog; (b) to investigate whether the renal effects of one or more of these agents could be shown to act either synergistically or antagonistically to the others and/or to vitamin D; and (c) to attempt to elucidate the mechanism(s) by which the actions of TCT, cAMP, and vitamin D on renal reabsorptive processes might be interrelated.
METHODS
Acute clearance studies, each lasting approximately 6-8 h, were performed on female mongrel dogs weighing [16] [17] [18] [19] [20] [21] [22] kg which had been thyroparathyroidectomized (TPTX) at least 3 days before their use in an experimental study. Completeness of glandular ablation was confirmed by a postoperative decline in serum calcium concentration of at least 30%o, and thyroid hormone was replaced as synthroid, 0.3 mg/day by mouth. In general, tetany was treated with calcium infusion, but occasionally parathyroid extract (Lilly) was required. In these cases, the animals were allowed to stabilize for an additional period of at least 48 h before study. Vasopressin tannate in oil (1 cc, Parke, Davis & Co.) was given 16 h before the experiment, and the dogs were deprived of food and water overnight. To obviate any influence of diurnal variations in electrolyte excretion on the results of these studies, all of the experiments were performed during the same time period, which began at 8:00 a.m. Light anesthesia was induced either with sodium pentothal (25 mg/kg) or sodium pentobarbital (20 mg/kg). A retention catheter was p)assed into the bladder, and polyethylene cannulas were introduced into a hindlimb vein for the infusion of fluids and into a jugular vein for the withdrawal of blood specimens. An endotracheal tube was passed anfd the dogs were ventilated with a Harvard respirator. Inulin, p-aminohippurate (PAH) and aqueous vasopressin (ADH) were infused in physiological saline solution at a rate of 1 ml/min in quantities sufficient to provide plasma levels of [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] mg/100 ml and 1-3 mg/100 ml for the former two substances, and to deliver 30-60 mU/kg per h of the latter. After an equilibration period of 50-60 min, the following experimental maneuvers were performed.
Hydropenic studies. In five dogs, after the collection of two to four control periods, porcine or salmon calcitonin,2 in dosages of from 1 to 100 MRC U/h was infused for a period of 21 to 3 h during which time urine collections were continued. The powdered hormone was diluted in normal saline solution (the pH of which was adjusted to 4 .0 with HCl) to an appropriate final concentration and was administered with a constant infusion pump in a volume of 0.02-0.04 ml/min. In some of the experiments, a 1-2% solution of gelatin was added to the TCT infusion for purposes of "stabilizing" the material. However, since the addition of this substance had no apparent effect, its use was discontinued.
Volume expansion studies. In these studies, animals were expanded with 25-30 ml/kg physiological saline solution 2Kindly supplied by Dr. James Bastian, Armour Pharmaceutical Co., Kankakee, Ill. containing 4-4.5 mEq/liter calcium over a 20-30 min period, after which the infusion rate was adjusted constantly to match urine flow. As in previous studies from this laboratory (24, 25) , this moderate degree of volume expansion (approximately 2.5% body wt) was utilized as the "control" situation because, in hydropenic, TPTX animals, phosphate excretion is so low as to render any further decline difficult or impossible to detect (24) . Steady-state expansion was considered to have been achieved when the urinary flow rate of five to seven consecutive 10-min urine collections did not vary by more than +5%o.
In nine such experiments, an infusion of 25HCC' was then begun at a rate of 0.02-0.04 ml/min so that approximately 60 U of this substance, dissolved in propylene glycol, was delivered per hour. 2 h later, TCT in dosages from 1 to 100 MRC U/h was begun as a continuous infusion for an additional 2 h while 25HCC administration was continued.
In 11 additional experiments, after the accomplishment of steady-state saline diuresis, the sequence of administration of the two agents was reversed. TCT was begun first, in dosages of from 40 to 100 MRC U/h, and then, after 2 h, 25HCC infusion (50-60 U/h) was added while the TCT administration continued.
Another 10 animals were expanded in the same manner as that described above, but the saline solution in these studies contained calcium in a concentration of 15-20 mEq/ liter. In five of these studies 25HCC was then infused for 22-3 h, while in the other five experiments only the vehicle (propylene glycol) was given, at the same rate (0.02 ml/ min) as that used for the metabolite, once steady-state expansion had been achieved. cAMP studies. In seven experiments, dibutyryl cAMP (Schwarz-Mann) was infused intravenously at a rate of approximately 50 mg/h for 11-2 h (in a total volume of 0.04 ml/min) in hydropenic animals. The intravenous administration of 25HCC (50-60 U/h) was then superimposed on the cAMP infusion for an additional 2 h. Analytical methods. Blood samples were obtained at the end of the equilibration period, just before the introduction of each experimental maneuver, and at intervals of 30-45 min throughout the studies. Urine was collected every 10-30 min by means of air washout and/or manual bladder compression. Blood and urine samples were analyzed for inulin, PAH, calcium, phosphate, sodium, and potassium by methods previously described (24) .
Blood for calcium and phosphate was obtained under mineral oil, the serum was separated anaerobically, and each sample was then centrifuged through a pre-wetted CF-50 centrifuge cone (Amicon Corp., Lexington, Mass.) to which oil had been added, in order to determine the ultrafilterable serum concentration of these ions. t-0_ 00 0' C4 V 00. >0 .
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RESULTS
Combination studies: 25HCC and TCT. In Table I , part A, are given the results of those studies in which the infusion of TCT was superimposed upon the renal effects of 25HCC. It has previously been determined in this laboratory that the administration of propylene glycol alone, during sustained volume expansion of this degree leads either to no change (25) or a slight rise (24) in the excretion of phosphate, sodium, and calcium as the expanded state is maintained. Similar to the findings in the former studies (24) , the administration of 25HCC to the saline-expanded animals resulted in an invariable fall in the absolute and fractional excretion rates for phosphate, sodium, and calcium in each of the nine studies. In addition, potassium excretion also declined. The absolute excretion rates of phosphate (UPV), sodium (UNAV), calcium (UcaV), and potassium (UKV) fell by 41.5% (P <0.005), 24.2% (P < 0.005), 13 .9% (P < 0.01), and 20.0% (P < 0.02), respectively. There was a mean reduction in fractional phosphate excretion of 42% from control levels (P < 0.005), and the decrements for sodium, potassium, and calcium were 23.4% (P < 0.001), 14.7% (P <0.005), and 13 .9% (P <0.01), respectively. Furthermore, these decreases in electrolyte excretion were not accompanied by any significant variation in GFR (CIn), effective renal plasma flow (CPATI), or filtration fraction (FF), nor were there any consistent changes in serum ultrafilterable (SUF) calcium or phosphate. When porcine (three experiments) or salmon (six studies) TCT in dosages from 1 to 100 MRC U/h was added to the infusion of 25HCC, the absolute and fractional excretion rates of the ions under study, as well as the measurements of renal hemodynamics and the value for SUF phosphate, remained stable. There was a mild increase in the SUF calcium value which was statistically significant at the 0.05 level.
In the second set of experiments, the order of administration of the two agents was reversed (Table I, (Table  I) , statistically significant differences were obtained by analysis of covariance for each of the fractional and absolute excretion rates, with a single exception, when the changes produced by 25HCC in hypocalcemic animals (Table I , part A) were compared to those induced by the metabolite in hypercalcemic dogs (Table V, part B). In this group of studies, Uc.V did not reach statistical significance, most likely because of the varying base line levels of calciuria resulting from the infusion of large amounts of calcium. Results of the covariant analyses were: UPV, P < 0.05; CP/CIn, P <0.01; UNaV, P < 0.05; CN&/CIn, P < 0.025; UCaV, P > 0.10; Cca/Cin, P < 0.05; UKV, P < 0.025; CK/CIn, P < 0.025. The 25HCC utilized in these studies, which was obtained as a single lot, was suspended in propylene glycol and refrigerated. Its continued biological activity was verified by the fact that the studies were performed in random order; in particular, the final experiment in this series was that listed as number 9 in Table I , part A, in which the metabolite produiced its expected action on electrolyte transport.
DISCUSSION
The experiments described in this comlimulnication were prompted by the findings obtained in this laboratory during a previous study of the renial actions of vitamin D and PTH (24, 25) . When base line phosplhate excretion in TPTX animals was elevated by means of mild volume expansion, it was possible to demonstrate that the acute effect of vitamin D and its metabolites on the kidney is the enhancement of phosphate, sodium, and calcium reabsorption (24, 25) . Furthermore, except when given in low dosage, PTH, administered before the infusion of 25HCC, could be shown to prevent these effects of the metabolite on phosphate transport from becoming manifest (24) . It therefore seemed pertinent to investigate the interactions of other agents which are important in controlling renal phosphate (as well as calcium and sodium) transport with regard to their capacity to influence the renal effects of vitamin D. Accordingly, the relationships between TCT, cAMP, 25HCC, and serum calcium concentration on ionic excretion were explored, a mechanism which might explain their individual and combined effects was proposed, and an attempt was made to evaluate this proposal. Major emphasis has been placed on the study of alterations in the excretion of the phosphate ion, not only because of the predominant effect of PTH on its renal reabsorption, but also because, unlike sodium and calcium, the bulk of its tubular transfer appears to be accomplished in the proximal nephron (32) (33) (34) .
The determination as to whether TCT does or does not possess a renal tubular action seems to depend not only upon the conditions of the experiment, but also on the species studied. Kenny and Heiskell first reported that the subcutaneous injection of a crude extract of thyroid gland induced a phosphaturia and subsequent hypophosphatemia, as well as hypocalcemia without calciuresis, in the intact rat (21 (38) . Details of the cellular processes by which the vitamin promotes an increased uptake of calcium, phosphate, sodium, and potassium by the renal tubular cell are, at present, poorly understood. In the gut, it has been suggested that a binding protein may effect the translocation of calcium, and that vitamin D induces the formation of this protein (39, 40) . Indeed, a similar material has been isolated in the kidney (41) . However, the fact that the tubular transfer of so many ions is affected by the metabolite suggests a more general action of the vitamin, perhaps related to alterations in membrane permeability, as has been suggested for intestinal calcium and phosphate transport (42) . An (Table  I) , succeeded in preventing the action of 25HCC onI the transport of these ions from becoming manifest (Table  IV) . The similar effects of TCT, cAMIP, and PTH (24) in blocking the action of 25HCC on renal tubular function could be explained on the basis that each of these agents affects electrolyte transport by a separate nmeclhanism, and that their respective abilities to prevent enhanced reabsorption due to the metabolite are entirely unrelated. Alternatively, since 25HCC does not appear to be the "tissue active" form of vitamin D in the kidney (24, 25) , it is possible that these agents prevent the conversion of 25HCC to that derivative of the vitamin which acts directly on the renal tubular cell. While experiments to test this postulate have not been performed. nevertheless there is available recent evidence wvhich indicates that while TCT does, in fact, inhibit the conversion of 25HCC to 1,25DHCC, on the other hand, PTH and cAMP enhance this reaction (49, 50) . However, if 1,25DHCC must be further mnetabolized before the kidney-active derivative is formed (25) , this hypothesis would have to be reevaluated.
A third contingency, which has the virtue of providing a unifying concept, is that intracellular calcium concentration is a major factor in the regulation of renal electrolyte transport. This thesis is prompted by the results of in vitro studies designed to examine the cellular events effected by the actions of PTH, TCT, and cAMP. Data obtained by Borle in his studies of calcium flux rates in kidney cells grown in tissue culture (29, [51] [52] [53] , as well as experimental observations from Rasmussen's laboratory in which isolated renal tubules were utilized as the test system (26, 27, 54, 55) have provided indirect evidence for the view that all three of these agents increase intracellular calcium content. We reasoned, therefore, that an increment in calcium concentration within the cell could have been the common factor responsible for preventing the vitamin D metabolite from enhancing calcium and phosphate (as well as sodium and potassium) uptake by the renal tubule. Since increases in extracellular calcium have been shown to result in elevations in the intracellular content of this ion (52, 56, 57) , we decided to test this hypothesis by evaluating whether merely increasing extracellular fluid calcium before administering the metabolite would have the same effect as did both of the hormonal substances and the cyclic nucleotide. In fact, this indeed proved to be the case (see Table V , part B) in that an approximately twofold increase in SUF calcium concentration abolished the usual effect of 25HCC on electrolyte excretion, whereas similar calcium elevations had no effect on transport, in and of themselves (Table V, part A) .
Therefore, to the extent that it is possible to extrapolate from the in vitro data cited above (29, (51) (52) (53) (54) (55) , our results are entirely compatible with the view that alterations in intracellular calcium concentration may play an important role in the regulation of renal transport, although in no sense can these observations be considered to constitute conclusive proof of this thesis. Rather, these data should serve to provide a working hypothesis, which will require further rigorous testing. The mechanism(s) by which alterations in intracellular calcium concentration might change renal electrolyte transport is unclear. The suggestion lhas been made that the ionic milieu of the cell may alter intermediary metabolism and thus affect the energy systems which fuel ionic pumping (27) . It seems likely that a complex series of interrelated biochemical and physicochemical reactions will ultimately be recognized as responsible for the interactions of humoral and ionic substances on renal tubular transport, an example of which interplay has been described in this report.
